These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8348264)

  • 1. Markers of endothelial perturbation and damage.
    Pearson JD
    Br J Rheumatol; 1993 Aug; 32(8):651-2. PubMed ID: 8348264
    [No Abstract]   [Full Text] [Related]  

  • 2. von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease.
    Blann AD
    J Rheumatol; 1993 Sep; 20(9):1469-71. PubMed ID: 8164200
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular damage and factor-VIII-related antigen in the rheumatic diseases.
    Belch JJ; Zoma AA; Richards IM; McLaughlin K; Forbes CD; Sturrock RD
    Rheumatol Int; 1987; 7(3):107-11. PubMed ID: 3118442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet involvement in cutaneous small vessel vasculitis.
    Meijer-Jorna LB; Mekkes JR; van der Wal AC
    J Cutan Pathol; 2002 Mar; 29(3):176-80. PubMed ID: 11972716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor: a marker of endothelial damage?
    Mannucci PM
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1359-62. PubMed ID: 9743222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endothelial dysfunction in rheumatic patients].
    Shilkina NP; Butusova SV
    Klin Med (Mosk); 2013; 91(4):58-61. PubMed ID: 23879057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rheumatic diseases and atherosclerosis: a role of rheological and microcirculatory impairments].
    Shilkina NP
    Angiol Sosud Khir; 2010; 16(2):23-9. PubMed ID: 21032869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective recognition of vascular lesions in Mondor's disease by immunohistochemistry.
    Ichinose A; Fukunaga A; Terashi H; Nishigori C; Tanemura A; Nakajima T; Akishima-Fukasawa Y; Ishikawa Y; Ishii T
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):168-73. PubMed ID: 18211409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase inhibitors potentiate the release of vasoactive mediators from human endothelium.
    Wheeler-Jones CP; Houliston RA; Morgan AJ; Pearson JD
    Biochem Soc Trans; 1995 May; 23(2):204S. PubMed ID: 7672224
    [No Abstract]   [Full Text] [Related]  

  • 11. Von Willebrand factor and endothelial damage in essential hypertension.
    Funiak S; Kubisz P; Kvetensky J; Cronberg S
    J Hum Hypertens; 1995 Aug; 9(8):705. PubMed ID: 8523395
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers of inflammation and endothelial function: the holy grail of experimental and clinical medicine?
    Biasucci LM; Cardillo MT
    Vascul Pharmacol; 2012; 56(1-2):26-8. PubMed ID: 22198643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is raised von Willebrand factor a marker of endothelial cell damage?
    Blann AD
    Med Hypotheses; 1993 Nov; 41(5):419-24. PubMed ID: 8145653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis.
    Kevil CG; Bullard DC
    Am J Med; 1999 Jun; 106(6):677-87. PubMed ID: 10378627
    [No Abstract]   [Full Text] [Related]  

  • 15. The central role of the endothelium in the pathogenesis of vasculitides.
    Lombardi A; Matucci-Cerinic M; Pignone A; Biagini M; Kahaleh BM
    Int Angiol; 1995 Jun; 14(2):175-82. PubMed ID: 8609444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases.
    Domiciano DS; Carvalho JF; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1233-8. PubMed ID: 19880574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating endothelial antigen.
    Carson CW; Hunder GG; Kaplan KL; Johnson CM
    J Rheumatol; 1991 Mar; 18(3):379-83. PubMed ID: 1856807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution.
    Reinders JH; Vervoorn RC; Verweij CL; van Mourik JA; de Groot PG
    J Cell Physiol; 1987 Oct; 133(1):79-87. PubMed ID: 3499441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease.
    Blann AD; Farrell A; Picton A; McCollum CN
    Thromb Res; 2000 Feb; 97(4):209-16. PubMed ID: 10674407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines, fibrinolysis and vasculitis.
    Teofoli P; Lotti T
    Int Angiol; 1995 Jun; 14(2):125-9. PubMed ID: 8609438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.